Cargando…
Legumain Promotes Atherosclerotic Vascular Remodeling
Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539540/ https://www.ncbi.nlm.nih.gov/pubmed/31060209 http://dx.doi.org/10.3390/ijms20092195 |
_version_ | 1783422413391790080 |
---|---|
author | Ozawa, Nana Sato, Yuki Mori, Yukari Masuda, Hiroko Yamane, Mao Yamamoto, Yuka Shirai, Remina Watanabe, Rena Sato, Kengo Mori, Yusaku Hirano, Tsutomu Watanabe, Takuya |
author_facet | Ozawa, Nana Sato, Yuki Mori, Yukari Masuda, Hiroko Yamane, Mao Yamamoto, Yuka Shirai, Remina Watanabe, Rena Sato, Kengo Mori, Yusaku Hirano, Tsutomu Watanabe, Takuya |
author_sort | Ozawa, Nana |
collection | PubMed |
description | Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and atherosclerosis formation is not clear. We assessed the expression of legumain in aortic atheromatous plaques and after wire-injury-induced femoral artery neointimal thickening and investigated the effect of chronic legumain infusion on atherogenesis in Apoe(−/−) mice. We also investigated the associated cellular and molecular mechanisms in vitro, by assessing the effects of legumain on inflammatory responses in HUVECs and THP-1 monocyte-derived macrophages; macrophage foam cell formation; and migration, proliferation, and extracellular matrix protein expression in human aortic smooth muscle cells (HASMCs). Legumain was expressed at high levels in atheromatous plaques and wire injury-induced neointimal lesions in Apoe(−/−) mice. Legumain was also expressed abundantly in THP-1 monocytes, THP-1 monocyte-derived macrophages, HASMCs, and HUVECs. Legumain suppressed lipopolysaccharide-induced mRNA expression of vascular cell adhesion molecule-1 (VCAM1), but potentiated the expression of interleukin-6 (IL6) and E-selectin (SELE) in HUVECs. Legumain enhanced the inflammatory M1 phenotype and oxidized low-density lipoprotein-induced foam cell formation in macrophages. Legumain did not alter the proliferation or apoptosis of HASMCs, but it increased their migration. Moreover, legumain increased the expression of collagen-3, fibronectin, and elastin, but not collagen-1, in HASMCs. Chronic infusion of legumain into Apoe(−/−) mice potentiated the development of atherosclerotic lesions, accompanied by vascular remodeling, an increase in the number of macrophages and ASMCs, and increased collagen-3 expression in plaques. Our study provides the first evidence that legumain contributes to the induction of atherosclerotic vascular remodeling. |
format | Online Article Text |
id | pubmed-6539540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65395402019-06-04 Legumain Promotes Atherosclerotic Vascular Remodeling Ozawa, Nana Sato, Yuki Mori, Yukari Masuda, Hiroko Yamane, Mao Yamamoto, Yuka Shirai, Remina Watanabe, Rena Sato, Kengo Mori, Yusaku Hirano, Tsutomu Watanabe, Takuya Int J Mol Sci Article Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and atherosclerosis formation is not clear. We assessed the expression of legumain in aortic atheromatous plaques and after wire-injury-induced femoral artery neointimal thickening and investigated the effect of chronic legumain infusion on atherogenesis in Apoe(−/−) mice. We also investigated the associated cellular and molecular mechanisms in vitro, by assessing the effects of legumain on inflammatory responses in HUVECs and THP-1 monocyte-derived macrophages; macrophage foam cell formation; and migration, proliferation, and extracellular matrix protein expression in human aortic smooth muscle cells (HASMCs). Legumain was expressed at high levels in atheromatous plaques and wire injury-induced neointimal lesions in Apoe(−/−) mice. Legumain was also expressed abundantly in THP-1 monocytes, THP-1 monocyte-derived macrophages, HASMCs, and HUVECs. Legumain suppressed lipopolysaccharide-induced mRNA expression of vascular cell adhesion molecule-1 (VCAM1), but potentiated the expression of interleukin-6 (IL6) and E-selectin (SELE) in HUVECs. Legumain enhanced the inflammatory M1 phenotype and oxidized low-density lipoprotein-induced foam cell formation in macrophages. Legumain did not alter the proliferation or apoptosis of HASMCs, but it increased their migration. Moreover, legumain increased the expression of collagen-3, fibronectin, and elastin, but not collagen-1, in HASMCs. Chronic infusion of legumain into Apoe(−/−) mice potentiated the development of atherosclerotic lesions, accompanied by vascular remodeling, an increase in the number of macrophages and ASMCs, and increased collagen-3 expression in plaques. Our study provides the first evidence that legumain contributes to the induction of atherosclerotic vascular remodeling. MDPI 2019-05-04 /pmc/articles/PMC6539540/ /pubmed/31060209 http://dx.doi.org/10.3390/ijms20092195 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ozawa, Nana Sato, Yuki Mori, Yukari Masuda, Hiroko Yamane, Mao Yamamoto, Yuka Shirai, Remina Watanabe, Rena Sato, Kengo Mori, Yusaku Hirano, Tsutomu Watanabe, Takuya Legumain Promotes Atherosclerotic Vascular Remodeling |
title | Legumain Promotes Atherosclerotic Vascular Remodeling |
title_full | Legumain Promotes Atherosclerotic Vascular Remodeling |
title_fullStr | Legumain Promotes Atherosclerotic Vascular Remodeling |
title_full_unstemmed | Legumain Promotes Atherosclerotic Vascular Remodeling |
title_short | Legumain Promotes Atherosclerotic Vascular Remodeling |
title_sort | legumain promotes atherosclerotic vascular remodeling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539540/ https://www.ncbi.nlm.nih.gov/pubmed/31060209 http://dx.doi.org/10.3390/ijms20092195 |
work_keys_str_mv | AT ozawanana legumainpromotesatheroscleroticvascularremodeling AT satoyuki legumainpromotesatheroscleroticvascularremodeling AT moriyukari legumainpromotesatheroscleroticvascularremodeling AT masudahiroko legumainpromotesatheroscleroticvascularremodeling AT yamanemao legumainpromotesatheroscleroticvascularremodeling AT yamamotoyuka legumainpromotesatheroscleroticvascularremodeling AT shirairemina legumainpromotesatheroscleroticvascularremodeling AT watanaberena legumainpromotesatheroscleroticvascularremodeling AT satokengo legumainpromotesatheroscleroticvascularremodeling AT moriyusaku legumainpromotesatheroscleroticvascularremodeling AT hiranotsutomu legumainpromotesatheroscleroticvascularremodeling AT watanabetakuya legumainpromotesatheroscleroticvascularremodeling |